James V. Cassella, SVP, Research & Development at Alexza Pharmaceuticals Inc. (ALXA), sold 24,424 shares at $2.41 ($54K) on 2009-12-16, disclosed to the SEC on 2009-12-18.
Scheduled sale ($54k) by SVP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.41 | 7,732 | $19K | 34.2% |
| 2 | $2.20 | 4,284 | $9K | 17.3% |
| 3 | $2.13 | 12,408 | $26K | 48.5% |
| Total | $2.23 avg | 24,424 | $54K | 100% |
| Filing → |
| CNCE | SELL | 2023-01-09 | $21K | — | Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |